U.S. flag

An official website of the United States government

NM_004928.3(CFAP410):c.319T>C (p.Tyr107His) AND Retinal dystrophy with or without macular staphyloma

Germline classification:
Pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003227769.1

Allele description [Variation Report for NM_004928.3(CFAP410):c.319T>C (p.Tyr107His)]

NM_004928.3(CFAP410):c.319T>C (p.Tyr107His)

Gene:
CFAP410:cilia and flagella associated protein 410 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_004928.3(CFAP410):c.319T>C (p.Tyr107His)
HGVS:
  • NC_000021.9:g.44333087A>G
  • NG_032952.1:g.11316T>C
  • NM_001271440.2:c.319T>C
  • NM_001271441.2:c.319T>C
  • NM_001271442.1:c.196T>C
  • NM_004928.3:c.319T>CMANE SELECT
  • NP_001258369.1:p.Tyr107His
  • NP_001258370.1:p.Tyr107His
  • NP_001258371.1:p.Tyr66His
  • NP_004919.1:p.Tyr107His
  • NC_000021.8:g.45752970A>G
  • NM_004928.2:c.319T>C
Protein change:
Y107H; TYR107HIS
Links:
OMIM: 603191.0008; dbSNP: rs763623409
NCBI 1000 Genomes Browser:
rs763623409
Molecular consequence:
  • NM_001271440.2:c.319T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001271441.2:c.319T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001271442.1:c.196T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004928.3:c.319T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Retinal dystrophy with or without macular staphyloma
Identifiers:
MONDO: MONDO:0060507; MedGen: C4479651; OMIM: 617547

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003924253Henan Ocular Pharmacology and Therapeutics International Laboratory, Henan Eye Hospital
no assertion criteria provided
Pathogenicbiparentalresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Asiabiparentalyesnot providednot providednot providednot providednot providedresearch

Details of each submission

From Henan Ocular Pharmacology and Therapeutics International Laboratory, Henan Eye Hospital, SCV003924253.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Asianot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1biparentalyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 15, 2024